Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,382,313
-
Total 13F shares
-
9,682,082
-
Share change
-
+275,060
-
Total reported value
-
$30,449,817
-
Price per share
-
$3.14
-
Number of holders
-
23
-
Value change
-
+$1,528,632
-
Number of buys
-
12
-
Number of sells
-
10
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q2 2022
As of 30 Jun 2022 TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,682,082 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., Deer Management Co. LLC, Alphabet Inc., TANG CAPITAL MANAGEMENT LLC, DC Funds, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Newtyn Management, LLC, VANGUARD GROUP INC, and Tekla Capital Management LLC.
This table shows 23 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.